Hypertensive disorders (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) · women with gestational diabetes mellitus
Probiotic showed no clear difference in hypertensive disorders (including pre‐eclampsia, pregnancy‐induced… compared with placebo (low certainty).
1 finding from 1 review
Composite outcome in infant (death, shoulder dystocia, nerve palsy, bone fracture) · women with gestational diabetes mellitus
1 finding from 1 review
Neurosensory disability · women with gestational diabetes mellitus
1 finding from 1 review
Neonatal hypoglycaemia requiring treatment (variously defined) · women with gestational diabetes mellitus
Probiotic showed no clear difference in neonatal hypoglycaemia requiring treatment (variously defined) compared with placebo (low certainty).
1 finding from 1 review
Adiposity · women with gestational diabetes mellitus
1 finding from 1 review
Diabetes(type1 or type2) or impaired glucose tolerance (child/adult) · women with gestational diabetes mellitus
1 finding from 1 review
Development of type 2 diabetes · women with gestational diabetes mellitus
1 finding from 1 review
Caesarean birth№ of participants: 159(2 RCTs) · women with gestational diabetes mellitus
Probiotic showed no clear difference in mode of birth (caesarean) compared with placebo (low certainty).
1 finding from 1 review
Induction of labour · women with gestational diabetes mellitus
It is very uncertain whether probiotic changes induction of labour compared with placebo (very low certainty).
1 finding from 1 review
Perineal trauma · women with gestational diabetes mellitus
1 finding from 1 review
Postnatal weight retention or return to pre‐pregnancy weight · women with gestational diabetes mellitus
1 finding from 1 review
Postnatal depression · women with gestational diabetes mellitus
1 finding from 1 review
Perinatal mortality · women with gestational diabetes mellitus
1 finding from 1 review
Large‐for‐gestational age · women with gestational diabetes mellitus
Probiotic showed no clear difference in large‐for‐gestational age > 90 centile compared with placebo (low certainty).
1 finding from 1 review
Maternal blood loss of 500 mL or greater · women in the third stage of labour
Oxytocin may leads to lower blood loss 500 mL or more after delivery compared with no uterotonics or placebo (low certainty).
1 finding from 1 review
Need for additional uterotonics · women in the third stage of labour
Oxytocin probably leads to lower need for additional uterotonics compared with no uterotonics or placebo (moderate certainty).
1 finding from 1 review
Maternal mortality ‐ not reported · women in the third stage of labour
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Severe PPH (≥ 1000 mL) · women in the third stage of labour
Oxytocin may leads to lower blood loss 1000 mL or more after delivery compared with no uterotonics or placebo (low certainty).
1 finding from 1 review
Blood transfusion · women in the third stage of labour
Oxytocin showed no clear difference in blood transfusion compared with no uterotonics or placebo (low certainty).
1 finding from 1 review
Third stage > 30 minutes · women in the third stage of labour
Oxytocin showed no clear difference in third stage greater than 30 minutes compared with no uterotonics or placebo (moderate certainty).
1 finding from 1 review